Table 2.

Characteristics of 3 Groups of US Adults With Treated Hypertension and SBP <140 in NHANES 2009 to 2012

Group VariableSPRINT-Like Adults ≥50 yAll Adults ≥18 y No ExclusionsAdults ≥18 y With Exclusions*
Sample, N4351979584
Population, N8 519 12737 583 37213 056 966
Age, y67.4±0.360.4±0.154.7±0.3
Female, %37.0±2.454.7±1.568.1±2.8
White, %85.9±1.973.6±2.676.5±3.4
Black, %7.0±1.013.8±1.714.8±2.6
Hispanic, %4.3±1.27.3±1.55.5±1.2
SBP, mm Hg123.3±1.0120.9±0.3118.9±0.6
SBP <135, %88.3±1.689.8±0.793.6±1.0
SBP <130, %68.3±3.274.8±1.183.4±2.0
SBP <125, %47.7±3.958.0±1.468.4±2.4
SBP <120, %30.5±2.841.5±1.047.8±2.7
  • Data are presented as mean and standard error of the mean. CHF indicates chronic heart failure; eGFR, estimated glomerular filtration rate; NHANES, National Health and Nutrition Examination Survey; SBP, systolic blood pressure; and SPRINT, Systolic Blood Pressure Intervention Trial.

  • * Exclusions included adults in the SPRINT-like group and SPRINT exclusions in other individuals, for example, diabetes mellitus, eGFR <20 mL/1.73 m2/min or urine/albumin >600 mg/g creatinine, CHF, SBP, and number of medications shown in Figure 1, and 0–1 annual health-care visits.